These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 27319211)

  • 21. Exosomes: Multiple-targeted multifunctional biological nanoparticles in the diagnosis, drug delivery, and imaging of cancer cells.
    Zheng Y; Hasan A; Nejadi Babadaei MM; Behzadi E; Nouri M; Sharifi M; Falahati M
    Biomed Pharmacother; 2020 Sep; 129():110442. PubMed ID: 32593129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers.
    Maheshwari R; Tekade M; Gondaliya P; Kalia K; D'Emanuele A; Tekade RK
    Nanomedicine (Lond); 2017 Nov; 12(21):2653-2675. PubMed ID: 28960165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Biological Function and Therapeutic Potential of Exosomes in Cancer: Exosomes as Efficient Nanocommunicators for Cancer Therapy.
    Choi JU; Park IK; Lee YK; Hwang SR
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33028046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting.
    Kim SM; Yang Y; Oh SJ; Hong Y; Seo M; Jang M
    J Control Release; 2017 Nov; 266():8-16. PubMed ID: 28916446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
    Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M
    Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How can nanotechnology help membrane vesicle-based cancer immunotherapy development?
    Tian X; Zhu M; Nie G
    Hum Vaccin Immunother; 2013 Jan; 9(1):222-5. PubMed ID: 23108359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering exosomes as refined biological nanoplatforms for drug delivery.
    Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
    Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. State-of-the-art exosome loading and functionalization techniques for enhanced therapeutics: a review.
    Donoso-Quezada J; Ayala-Mar S; González-Valdez J
    Crit Rev Biotechnol; 2020 Sep; 40(6):804-820. PubMed ID: 32605394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosomes and cancer: From oncogenic roles to therapeutic applications.
    Mohammadi S; Yousefi F; Shabaninejad Z; Movahedpour A; Mahjoubin Tehran M; Shafiee A; Moradizarmehri S; Hajighadimi S; Savardashtaki A; Mirzaei H
    IUBMB Life; 2020 Apr; 72(4):724-748. PubMed ID: 31618516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Exosome-Mediated Small RNA Delivery For Gene Therapy].
    Sun W; Cao FJ; Wang N; Zhou Y; Ba Y; Zhang CY
    Sheng Li Ke Xue Jin Zhan; 2016 Jun; 47(3):162-7. PubMed ID: 29888878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosome-mediated small RNA delivery for gene therapy.
    Zhou Y; Zhou G; Tian C; Jiang W; Jin L; Zhang C; Chen X
    Wiley Interdiscip Rev RNA; 2016 Nov; 7(6):758-771. PubMed ID: 27196002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Designer exosomes as next-generation cancer immunotherapy.
    Bell BM; Kirk ID; Hiltbrunner S; Gabrielsson S; Bultema JJ
    Nanomedicine; 2016 Jan; 12(1):163-9. PubMed ID: 26500074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges.
    Syn NL; Wang L; Chow EK; Lim CT; Goh BC
    Trends Biotechnol; 2017 Jul; 35(7):665-676. PubMed ID: 28365132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosome Mediated Cancer Therapeutic Approach:Present Status and Future Prospectives.
    Roy A; Girija As S; Sankar Ganesh P; Saravanan M; Sunny B
    Asian Pac J Cancer Prev; 2023 Feb; 24(2):363-373. PubMed ID: 36853283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation.
    Alfonsi R; Grassi L; Signore M; Bonci D
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].
    Sundararajan V; Sarkar FH; Ramasamy TS
    Cell Oncol (Dordr); 2018 Jun; 41(3):223-252. PubMed ID: 29667069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organically derived exosomes as carriers of anticancer drugs and imaging agents for cancer treatment.
    Srivastava A; Rathore S; Munshi A; Ramesh R
    Semin Cancer Biol; 2022 Nov; 86(Pt 1):80-100. PubMed ID: 35192929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosomes and their Application in Biomedical Field: Difficulties and Advantages.
    Rezaie J; Ajezi S; Avci ÇB; Karimipour M; Geranmayeh MH; Nourazarian A; Sokullu E; Rezabakhsh A; Rahbarghazi R
    Mol Neurobiol; 2018 Apr; 55(4):3372-3393. PubMed ID: 28497202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exosome-like Nanovectors for Drug Delivery in Cancer.
    Arrighetti N; Corbo C; Evangelopoulos M; Pastò A; Zuco V; Tasciotti E
    Curr Med Chem; 2019; 26(33):6132-6148. PubMed ID: 30182846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosome as a Delivery Vehicle for Cancer Therapy.
    Moon B; Chang S
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.